• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Predictions for the next round...

Anonymous

Guest
Ok, now that the new "Management Team" is in place, let's hear your predictions for the next round. Who stays, who goes from the director management level? Who do you see as safe? If it were you making the decisions, who would you keep? Field, home office, RTP, etc...
 

<



Here's one list to build upon.

Sr Dir of sales training (JL)
Exec Dir of market research (PS)
A large number of marketing directors on products that were not identified at the 2/4 town hall as the organization's focus (CS, NM to start)
 




Ok, now that the new "Management Team" is in place, let's hear your predictions for the next round. Who stays, who goes from the director management level? Who do you see as safe? If it were you making the decisions, who would you keep? Field, home office, RTP, etc...

Speaking of which, how excited are you about the "management team" left in place? How will they make Eis become successful? What will be different?
 








Excited? Not until we see who else goes and what our severance package will be.

Don't get your hopes up on a large severance package. You'll get maybe a max of 3-6 months salary. The comments about people wanting to know what the severance package will be makes me laugh. Do you think you'll get $1million? Too funny.